These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6313904)

  • 1. Inhibition of the spontaneous climbing behavior elicited in mice by opiates.
    Marcais-Collado H; Chaillet P; Costentin J
    J Pharmacol Exp Ther; 1983 Nov; 227(2):466-71. PubMed ID: 6313904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assessment of the opiate-induced modifications in the vertical and horizontal components of locomotor activity in mice.
    Chaillet P; Durand MA; Marçais-Collado H; Costentin J
    J Pharmacol; 1984; 15(3):375-83. PubMed ID: 6092786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigm.
    Milman A; Weizman R; Rigai T; Rice KC; Pick CG
    Behav Brain Res; 2006 Jun; 170(1):141-7. PubMed ID: 16574254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective antagonism of mu(1)-, mu(1/2)-, mu(3)-, and delta-opioid receptors on the locomotor-stimulating actions of ethanol.
    Pastor R; Sanchis-Segura C; Aragon CM
    Drug Alcohol Depend; 2005 Jun; 78(3):289-95. PubMed ID: 15893160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
    Zernig G; Burke T; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
    Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
    Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
    Hiramatsu M; Hoshino T; Kanematsu K
    Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine sex-dependently induced place conditioning in adult Wistar rats.
    Karami M; Zarrindast MR
    Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary-reinforcing effects of opiate agonists in the mouse].
    Zvartau EE; Kovalenko VS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1986; 36(6):1069-76. PubMed ID: 3031897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization.
    Leite-Morris KA; Fukudome EY; Shoeb MH; Kaplan GB
    J Pharmacol Exp Ther; 2004 Feb; 308(2):667-78. PubMed ID: 14610238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A steric theory of opioid agonists, antagonists, agonist-antagonists, and partial agonists.
    Martin WR
    NIDA Res Monogr; 1984 Mar; 49():16-23. PubMed ID: 6090916
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide and nonpeptide ligands for opioid receptors.
    Misicka A
    Acta Pol Pharm; 1995; 52(5):349-63. PubMed ID: 8960271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?
    Welch SP; Dunlow LD
    J Pharmacol Exp Ther; 1993 Oct; 267(1):390-9. PubMed ID: 8229767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.